14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 AVRO stock ended at $1.25. This is 0.81% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.05% from a day low at $1.23 to a day high of $1.27.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical AVROBIO Inc prices

Date Open High Low Close Volume
Aug 01, 2018 $32.07 $33.38 $30.16 $31.83 25 241
Jul 31, 2018 $32.00 $32.00 $30.10 $32.00 35 091
Jul 30, 2018 $31.68 $33.27 $31.68 $32.08 25 875
Jul 27, 2018 $33.35 $34.06 $28.41 $31.53 98 614
Jul 26, 2018 $38.71 $40.00 $33.01 $33.35 40 768
Jul 25, 2018 $39.04 $40.78 $34.50 $39.01 150 254
Jul 24, 2018 $37.90 $41.23 $37.90 $38.79 125 476
Jul 23, 2018 $36.56 $39.20 $36.56 $38.31 258 850
Jul 20, 2018 $35.26 $38.79 $34.27 $37.55 249 640
Jul 19, 2018 $34.49 $35.96 $32.42 $34.50 385 932
Jul 18, 2018 $29.83 $35.10 $29.58 $33.91 117 803
Jul 17, 2018 $28.90 $29.71 $28.00 $29.02 36 939
Jul 16, 2018 $28.48 $30.30 $28.00 $29.07 189 041
Jul 13, 2018 $29.40 $30.80 $27.88 $28.10 266 121
Jul 12, 2018 $28.38 $29.62 $27.30 $29.62 60 095
Jul 11, 2018 $28.04 $28.91 $26.54 $28.02 184 537
Jul 10, 2018 $27.97 $29.62 $26.81 $28.62 63 518
Jul 09, 2018 $28.74 $29.45 $27.34 $27.99 36 953
Jul 06, 2018 $27.59 $30.12 $27.18 $28.35 50 577
Jul 05, 2018 $27.01 $28.93 $27.01 $27.48 110 160
Jul 03, 2018 $27.15 $27.73 $26.51 $26.95 79 391
Jul 02, 2018 $28.61 $29.46 $26.51 $27.35 96 625
Jun 29, 2018 $27.81 $28.67 $27.49 $28.56 259 448
Jun 28, 2018 $30.50 $30.98 $27.02 $28.08 188 593
Jun 27, 2018 $30.44 $31.00 $30.02 $30.54 171 587
Click to get the best stock tips daily for free!

About AVROBIO Inc

AVROBIO AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry di... AVRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT